England's NICE OKs Shire’s Takhzyro For Rare Hereditary Disease
Executive Summary
England’s health technology assessment body has recommended the use of Shire’s orphan drug Takhzyro for use in patients with hereditary angioedema, but only in certain circumstances and provided the company offers the product at the agreed discounted price.